Cargando…
A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination
Treatment-resistant depression (TRD) occurs in many patients and causes high morbidity and mortality. Because TRD subjects are particularly difficult to study especially longitudinally, biological data remain very limited. In a preliminary study to judge feasibility and power, 25 TRD patients were r...
Autores principales: | Pardo, José V., Sheikh, Sohail A., Schwindt, Graeme, Lee, Joel T., Adson, David E., Rittberg, Barry, Abuzzahab, Faruk S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957341/ https://www.ncbi.nlm.nih.gov/pubmed/31931515 http://dx.doi.org/10.1371/journal.pone.0226486 |
Ejemplares similares
-
Olanzapine and fluoxetine combination in severe or resistant depression
por: Haridas, R.M., et al.
Publicado: (2003) -
Weight loss dynamics during combined fluoxetine and olanzapine treatment
por: Perrone, Jennifer A, et al.
Publicado: (2004) -
Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
por: Brunner, Elizabeth, et al.
Publicado: (2014) -
Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues
por: Bobo, William V, et al.
Publicado: (2009) -
Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan, Shuxin, et al.
Publicado: (2017)